
Makes learning interactive and fun.
Encourages students to think outside the box.
Creates a safe space for learning and growth.
Fair, constructive, and always motivating.
Always positive, enthusiastic, and supportive.
Dr. Tony Barnett serves as an Adjunct Lecturer in the Eastern Health Clinical School Research at Monash University, part of the Faculty of Medicine, Nursing and Health Sciences. He earned his PhD from Monash University in 2020, with a thesis examining clinicians' perspectives on the brain disease model of addiction and the integration of neuroscientific models and interventions into clinical practice. Barnett holds an MEd, BAppSc (Advanced Nursing), and professional qualifications as a Registered Nurse (RN), Fellow of the Royal College of Nursing Australia (FRCNA), and Fellow of the Royal Society of Arts (FRSA). His academic career includes a prior role as Associate Professor in the School of Nursing and Midwifery at Monash University, positions at the University of Tasmania's Department of Rural Health, and currently as a Research Fellow at The University of Queensland School of Psychology.
Barnett's research specializations encompass qualitative research, neuroethics, critical social science methods, opioid addiction, and harm reduction, with a focus on the social and cultural contexts of alcohol and other drug use, treatment—including novel interventions like depot buprenorphine—and policy change. Since joining Turning Point in 2018, he has contributed to the Clinical and Social Research team at the Monash Addiction Research Centre, leading projects on service user experiences at the Medically Supervised Injecting Room, telehealth delivery during the COVID-19 pandemic, clients' experiences with depot buprenorphine for opioid dependence, and Australian Defence Force veterans' transitions to civilian life emphasizing social group engagement. Key publications include "Experiences of telehealth among people receiving alcohol and other drug treatment during the COVID-19 pandemic: Implications for future telehealth delivery" (2024), "The dynamics of more-than-human care in depot buprenorphine treatment: A new materialist analysis of Australian patients’ experiences" (2024), "Keeping clients connected: exploring Australian alcohol and other drug clinicians’ perspectives on barriers and facilitators to treatment attendance" (2024), "Web-Based Forums for People Experiencing Substance Use or Gambling Disorders: Scoping Review" (2024), and "Complex trauma and perceived barriers to treatment among people accessing a supervised injecting facility" (2025). His earlier research addressed rural health, nursing education, interprofessional education, and oral health.
